4 Weeks Treatment With Empagliflozin (BI 10773) in Japanese Type 2 Diabetic Patients (T2DM)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this trial is to evaluate the pharmacodynamics, pharmacokinetics, safety,
and tolerability of once daily oral administration of BI 10773 administered for 28 days in
Japanese patients with T2DM.